drugset / Trial / NCT00223951
Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety of R89674 0.25% ophthalmic solution in healthy normal volunteers
Timeline
- Start
- 2005-09
- Primary completion
- 2005-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alcaftadine | Small molecule | 0.25 % | Other |
Indications
No indication recorded.